The Role of Glucose Mediated Glucose Uptake in the pathogenesis of IFG and IGT

葡萄糖介导的葡萄糖摄取在 IFG 和 IGT 发病机制中的作用

• 批准号: 8549227
• 负责人: Muhammad Abdul-Ghani
• 金额: $ 31.38万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-21 至 2017-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8549227
• 关键词: 1-Phosphatidylinositol 3-Kinase; Appearance; Applications Grants; Binding; Binding Proteins; Biochemical; Blood Circulation; Brain; Cell membrane; Clinical; Defect; Development; Equilibrium; Fasting; Future; GLUT 4 protein; GLUT-1 protein; GLUT-3 protein; GLUT4 gene; Gene Expression; Genes; Glucose; Glucose Plasma Concentration; Glucose Transporter; Grant; Hepatic; Hour; Hyperglycemia; Hyperinsulinism; IRS1 gene; Impaired fasting glycaemia; Impairment; Individual; Infusion Technique; Infusion procedures; Ingestion; Insulin; Insulin Resistance; Intervention; Liver; Mediating; Messenger RNA; Metabolic; Molecular; Muscle; Non-Insulin-Dependent Diabetes Mellitus; Pathogenesis; Physiological; Plasma; Proteins; Regulation; Risk; Role; SLC2A1 gene; SP1 gene; Skeletal Muscle; Somatostatin; Techniques; Tissues; Tracer; Tyrosine Phosphorylation; basal insulin; blood glucose regulation; fasting plasma glucose; glucose disposal; glucose production; glucose tolerance; glucose uptake; impaired glucose tolerance; improved; non-diabetic; novel; prevent; promoter; transcription factor

DESCRIPTION (provided by applicant): Subjects with impaired fasting glucose have increased risk of progression to T2DM. The metabolic defects responsible for the increase in FPG within the nondiabetic range have been poorly studied. A clearer understanding of the mechanisms of these defects will help to develop improved strategies to treat and prevent T2DM. We previously have shown that basal glucose clearance is decreased in IFG subjects. Since basal tissue glucose clearance takes place via glucose-mediated glucose uptake (GMGU) mechanisms, we hypothesize that impaired GMGU is the primary defect responsible for the rise in the FPG concentration in the non-diabetic range and development of IFG. In this grant proposal we will: (i) quantitate whole body GMGU with the stepped hyperglycemic clamp and somatostatin infusion, and insulin-mediated glucose uptake (IMGU) with the stepped euglycemic insulin clamp, (ii) the protein content of insulin dependent (GLUT4/GLUT12) and glucose-mediated glucose transporters (GLUT1/GLUT3/GLUT11) and gene expression in skeletal muscle in subjects with IFG, IGT and NGT; (iii) the level of transcription factors and mRNA binding proteins and their binding to GLUT1 gene promoter and GLUT1 mRNA and their relationship to GLUT1 level, and (iv) quantitate splanchnic glucose uptake (SGU) during basal state and following glucose ingestion to examine the contribution of decreased SGU to the decreased GMGU and excessive early rise in plasma glucose concentration in IFG subjects. We believe that the results of these studies will help define the molecular/biochemical/physiologic defects responsible for the development of IFG and help to elucidate effective strategies to correct these defects and revert IFG to NGT.

描述（由申请人提供）：空腹血糖受损的受试者进展为2型糖尿病的风险增加。在非糖尿病范围内，导致FPG增加的代谢缺陷的研究很少。更清楚地了解这些缺陷的机制将有助于制定更好的策略来治疗和预防2型糖尿病。我们之前的研究表明，IFG受试者的基础葡萄糖清除率降低。由于基础组织葡萄糖清除是通过葡萄糖介导的葡萄糖摄取（GMGU）机制发生的，我们假设GMGU受损是导致非糖尿病范围内FPG浓度升高和IFG发展的主要缺陷。在这项资助申请中，我们将：(i)用阶梯高血糖钳和生长抑素输注定量全身GMGU，用阶梯正糖胰岛素钳定量胰岛素介导的葡萄糖摄取（IMGU）， （ii）胰岛素依赖性（GLUT4/GLUT12）和葡萄糖介导的葡萄糖转运体（GLUT1/GLUT3/GLUT11）的蛋白质含量和骨骼肌中IFG、IGT和NGT受试者的基因表达；（iii）转录因子和mRNA结合蛋白的水平及其与GLUT1基因启动子和GLUT1 mRNA的结合及其与GLUT1水平的关系；（iv）在基础状态和葡萄糖摄入后定量测定内脏葡萄糖摄取（SGU），以检验SGU降低对IFG受试者GMGU降低和血浆葡萄糖浓度过早升高的贡献。我们相信这些研究结果将有助于确定导致IFG发展的分子/生化/生理缺陷，并有助于阐明纠正这些缺陷并使IFG恢复为NGT的有效策略。